intermediate risk

Commentary

Born From Risk: What Made TAVR Possible and the Future of a Transformational Technology

05/31/2017

Born from surgical risk considerations, TAVR ultimately will be defined by individualized outcomes. As we treat severe aortic stenosis among ever lower-risk patients, we will need to retain both TAVR and SAVR as possible options.

Born from surgical risk...

05/31/2017

Journal of Invasive Cardiology

Original Contribution

Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Low-Intermediate Surgical Risk Patients: A Systematic Review and Meta-Analysis

05/31/2017

Sahil Agrawal , MD;

Abhishek Danturi Sharma , MD;

Lohit Garg , MD;

Indrajeet Mahata , MD;

Jalaj Garg , MD, FACC, FESC;

Dinesh Singal , MD;

Marc S. Cohen , MD;

John B. Kostis , MD, PhD;

Sunil V. Rao , MD, FACC, FSCAI;

Aakash Garg , MD;

Gautam Visveswaran , MD;

We sought to evaluate the outcomes of TAVR vs SAVR in low-intermediate risk patients with severe aortic stenosis.

We sought to evaluate the...

05/31/2017

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

intermediate risk

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products